AQP4 and central nervous system cancer: The results indicated that low AQP4 expression was significantly correlated with lower clinical grade glioma (grade 1/2), while high AQP4 expression predicted higher clinical grade glioma (grade 3/4) in patients (Figure 1A) (X 2 = 12.434, p < 0.001).